Evidence map›Paper›PMID 19106632›Full record

ArticleCancer biology & therapy2008

Gamma-radiation (GR) triggers a unique gene expression profile associated with cell death compared to proton radiation (PR) in mice in vivo.

Niklas Finnberg, Chris Wambi, Jeffrey H Ware, Ann R Kennedy, Wafik S El-Deiry

Open access · bronzeAbstract read
In one paragraph

Article in Cancer biology & therapy, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 65 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Gene Expression Studies for the Development of Particle Therapy.International journal of particle therapy · 2018
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Niklas FinnbergLaboratory of Molecular Oncology and Cell Cycle Regulation, The Institute for Translational Medicine and Therapeutics, The Abramson Comprehensive Cancer Center, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.
Chris Wambi
Jeffrey H Ware
Ann R Kennedy
Wafik S El-Deiry
Translational Therapeutics (United States) · US

Funding

ROLE OF ATAXIA TELANGIECTASIA IN CHECKPOINT CONTROLP01CA075138 · NCI · UNIVERSITY OF PENNSYLVANIA · PI HAHN, STEPHEN M · 1998 to 2007
$11.6M
Optical Imaging of Tumor Physiologic/ Metabolic Changes in Antiangiogenic TherapyU54CA105008 · NCI · UNIVERSITY OF PENNSYLVANIA · PI EL-DEIRY, WAFIK S · 2003 to 2007
$6.4M
RADIATION BIOLOGY TRAINING GRANTT32CA009677 · NCI · UNIVERSITY OF PENNSYLVANIA · PI KENNEDY, ANN R · 1992 to 2011
$5.0M
NCI NIH HHS 2P01CA75138NCI NIH HHS 2T32CA09677NCI NIH HHS P01 CA075138NCI NIH HHS T32 CA009677NCI NIH HHS U54 CA105008NCI NIH HHS U54CA105008
6 · The paper itself

Abstract

Proton radiation (PR) therapy offers a number of potential advantages over conventional (photon) gamma-radiation (GR) therapy for cancer, due to a more localized delivery of the radiation dose. However, the pathophysiological effects following PR-exposure are less well characterized than those of GR-exposure and the molecular changes associated with the acute apoptotic effects in mice in vivo following PR have not been elucidated. Previous studies have estimated the RBE of protons for various in vivo and in vitro endpoints at between 1.1 and 1.3. We assumed an RBE of 1.1 for the endpoints to be evaluated in these studies. Based on this assumption, ICR mice were treated with whole-body doses of GR (1.1 and 7.0 Gy) and PR (1.0 and 6.4 Gy) that were expected to represent RBE-weighted doses. The bone marrow, thymus, spleen and GI-tract were isolated and processed for histology and immunohistochemistry. The apoptotic responses varied greatly between GR and PR in a tissue- and dose-dependent manner. Surprisingly,cell death in the splenic white pulp was consistently lower in PR-treated animals compared to animals treated with GR. This was in spite of an increased presence of damaged DNA following PR as determined by staining for gammaH2AX and phospho-ATM. Interestingly, both PR and GR triggered nuclear accumulation of p53 and no significant differences were found in the majority of the known pro-apoptotic p53-target genes in the spleens of treated mice. However, GR uniquely triggered a pro-apoptotic expression profile including expression of the pro-apoptotic, p53- and interferon stimulated target gene Bcl-G. In contrast to PR, GR may, in a cell type specific manner, trigger a more diverse non-random stress-response that mediates apoptosis partially independent of the extent of DNA damage.

Indexed as

Gamma RaysGene Expression ProfilingAnimalsApoptosisCell DeathCell LineColonL CellsLinear Energy TransferMiceNeoplasmsPeyer's PatchesProtonsProton TherapySpleenProtons

Identifiers

PMID19106632
PMCPMC3590842
OpenAlexW2079297041

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.